ArticleVaccine2022

Immunological features that associate with the strength of antibody responses to BNT162b2 mRNA vaccine against SARS-CoV-2.

Takahiro Kageyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.